80_FR_56657 80 FR 56476 - National Institute of Neurological Disorders and Stroke; Notice of Meeting

80 FR 56476 - National Institute of Neurological Disorders and Stroke; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 181 (September 18, 2015)

Page Range56476-56476
FR Document2015-23443

Federal Register, Volume 80 Issue 181 (Friday, September 18, 2015) 
[Federal Register Volume 80, Number 181 (Friday, September 18, 2015)]
[Notices]
[Page 56476]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-23443]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Muscular Dystrophy Coordinating Committee (MDCC).
    The meeting will be open to the public and accessible by live 
webcast.

    Name of Committee: Muscular Dystrophy Coordinating Committee.
    Type of meeting: Open Meeting.
    Date: November 13, 2015.
    Time: 8:30 a.m. to 4:30 p.m. *Eastern Time*--Approximate end 
time.
    Agenda: The purpose of this meeting is to bring together 
committee members, representing government agencies, patient 
advocacy groups, other voluntary health organizations, and patients 
and their families to update one another on progress relevant to the 
Action Plan for the Muscular Dystrophies and to coordinate 
activities and discuss gaps and opportunities leading to better 
understanding of the muscular dystrophies, advances in treatments, 
and reduced disease burden. Prior to the meeting, an agenda will be 
posted to the MDCC meeting registration Web site: https://meetings.ninds.nih.gov/meetings/MDCC13Nov2015/.
    Registration: To register, please go to: https://meetings.ninds.nih.gov/meetings/MDCC13Nov2015/.
    Webcast Live: For those not able to attend in person, this 
meeting will be webcast at: http://videocast.nih.gov/.
    Place: Neuroscience Center, Conference Room C/D, 6001 Executive 
Boulevard, Rockville, Maryland 20852.
    Contact Person: Glen H. Nuckolls, Ph.D., Executive Secretary, 
Muscular Dystrophy Coordinating Committee, National Institute of 
Neurological Disorders and Stroke, NIH, 6001 Executive Boulevard, 
NSC 2203, Rockville, MD 20852, (301) 496-5739, 
glen.nuckolls@ninds.nih.gov.

    Any member of the public interested in presenting oral comments 
to the committee may notify the Contact Person listed on this notice 
at least 10 days in advance of the meeting. Interested individuals 
and representatives of organizations may submit a letter of intent, 
a brief description of the organization represented, and a short 
description of the oral presentation. Only one representative of an 
organization may be allowed to present oral comments and if accepted 
by the committee, presentations may be limited to five minutes. Both 
printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
committee by forwarding their statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Attendance is limited to seating space available. Individuals 
who plan to attend and need special assistance, such as sign 
language interpretation or other reasonable accommodations, should 
inform the Contact Person listed above in advance of the meeting. 
All visitors must go through a security check at the meeting site to 
receive a visitor's badge. A valid, government issued photo ID must 
be presented before a visitor's badge can be issued. Further 
information can be found at the registration Web site: https://meetings.ninds.nih.gov/meetings/MDCC13Nov2015/.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

     Dated: September 14, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-23443 Filed 9-17-15; 8:45 am]
BILLING CODE 4140-01-P

56476 Federal Register / Vol. 80, No. 181 / Friday, September 18, 2015 / Notices Agenda: To review and evaluate grant Coordinating Committee, National Institute High Throughput Prioritization and applications. of Neurological Disorders and Stroke, NIH, Decision Making.’’ Attendees at the in- Place: Crowne Plaza Washington National 6001 Executive Boulevard, NSC 2203, person workshop and four webinar Airport, 1489 Jefferson Davis Hwy, Arlington, Rockville, MD 20852, (301) 496–5739, VA 22202. presentations leading up to the glen.nuckolls@ninds.nih.gov. Contact Person: Ryan G Morris, Ph.D., workshop will discuss the state of the Any member of the public interested in Scientific Review Officer, Center for presenting oral comments to the committee science and best practices for using in Scientific Review, National Institutes of may notify the Contact Person listed on this vitro to in vivo extrapolation (IVIVE) in Health, 6701 Rockledge Drive, Room 4205, notice at least 10 days in advance of the a tiered risk decision context. MSC 7814, Bethesda, MD 20892, 301–435– meeting. Interested individuals and DATES: Webinars: October 7, 2015, at 1501, morrisr@csr.nih.gov. representatives of organizations may submit 11:00 a.m. Eastern Daylight Time (EDT); (Catalogue of Federal Domestic Assistance a letter of intent, a brief description of the and November 4, 2015; December 2, Program Nos. 93.306, Comparative Medicine; organization represented, and a short 93.333, Clinical Research, 93.306, 93.333, 2015; and January 6, 2016; at 11:00 a.m. description of the oral presentation. Only one 93.337, 93.393–93.396, 93.837–93.844, Eastern Standard Time (EST). representative of an organization may be 93.846–93.878, 93.892, 93.893, National allowed to present oral comments and if Webinar Registration: Deadline is two Institutes of Health, HHS) accepted by the committee, presentations business days prior to each webinar. Dated: September 14, 2015. may be limited to five minutes. Both printed Workshop: February 17–18, 2016, and electronic copies are requested for the from 9:00 a.m. to approximately 5:00 Melanie J. Gray, record. In addition, any interested person p.m. (EST). Program Analyst, Office of Federal Advisory Workshop Registration: Deadline is may file written comments with the Committee Policy. committee by forwarding their statement to February 5, 2016 at 5:00 p.m. (EST). [FR Doc. 2015–23387 Filed 9–17–15; 8:45 am] the Contact Person listed on this notice. The ADDRESSES: BILLING CODE 4140–01–P statement should include the name, address, Workshop Location: U.S. telephone number and when applicable, the business or professional affiliation of the Environmental Protection Agency, 109 DEPARTMENT OF HEALTH AND interested person. T.W. Alexander Dr., Durham, NC, HUMAN SERVICES Attendance is limited to seating space 27709. available. Individuals who plan to attend and Web page: The preliminary agenda, National Institutes of Health need special assistance, such as sign registration, and other meeting materials language interpretation or other reasonable will be available at http:// National Institute of Neurological accommodations, should inform the Contact ntp.niehs.nih.gov/go/ivive-wksp-2016. Disorders and Stroke; Notice of Person listed above in advance of the FOR FURTHER INFORMATION CONTACT: Dr. Meeting meeting. All visitors must go through a security check at the meeting site to receive Warren S. Casey, Director, NICEATM; Pursuant to section 10(a) of the a visitor’s badge. A valid, government issued email: warren.casey@nih.gov; telephone: Federal Advisory Committee Act, as photo ID must be presented before a visitor’s (919) 316–4729. amended (5 U.S.C. App.), notice is badge can be issued. Further information can SUPPLEMENTARY INFORMATION: hereby given of a meeting of the be found at the registration Web site: Background: Data from high https://meetings.ninds.nih.gov/meetings/ throughput in vitro tests are being Muscular Dystrophy Coordinating MDCC13Nov2015/. generated for many chemicals of Committee (MDCC). The meeting will be open to the (Catalogue of Federal Domestic Assistance environmental and commercial interest, Program Nos. 93.853, Clinical Research with the expectation that in vitro assay public and accessible by live webcast. Related to Neurological Disorders; 93.854, data could ultimately be used to predict Name of Committee: Muscular Dystrophy Biological Basis Research in the Coordinating Committee. Neurosciences, National Institutes of Health, adverse effects of chemical exposures in Type of meeting: Open Meeting. HHS) vivo. Translating values obtained from Date: November 13, 2015. in vitro assays into estimates of in vivo Time: 8:30 a.m. to 4:30 p.m. *Eastern Dated: September 14, 2015. outcomes is a complex process Time*—Approximate end time. Carolyn Baum, involving the use of mathematical Agenda: The purpose of this meeting is to Program Analyst, Office of Federal Advisory modeling and increasingly complex test bring together committee members, Committee Policy. systems. The series of four webinars and representing government agencies, patient [FR Doc. 2015–23443 Filed 9–17–15; 8:45 am] advocacy groups, other voluntary health in-person workshop aim to address the organizations, and patients and their families BILLING CODE 4140–01–P capabilities and limitations of IVIVE to update one another on progress relevant to within the context of risk decision- the Action Plan for the Muscular Dystrophies making. and to coordinate activities and discuss gaps DEPARTMENT OF HEALTH AND The webinar series will present the and opportunities leading to better HUMAN SERVICES current science, and the in-person understanding of the muscular dystrophies, workshop will facilitate discussions that advances in treatments, and reduced disease National Institutes of Health follow-up and build on information burden. Prior to the meeting, an agenda will be posted to the MDCC meeting registration In Vitro to In Vivo Extrapolation for presented in the webinars. During the Web site: https://meetings.ninds.nih.gov/ High Throughput Prioritization and workshop, participants will (1) review meetings/MDCC13Nov2015/. Decision Making; Notice of Webinars the state of the science to form Registration: To register, please go to: and Public Workshop; Registration recommendations on best practices for https://meetings.ninds.nih.gov/meetings/ Information using IVIVE in chemical screening and MDCC13Nov2015/. risk-based decision making, (2) identify tkelley on DSK3SPTVN1PROD with NOTICES Webcast Live: For those not able to attend SUMMARY: The National Toxicology areas that require additional data and/or in person, this meeting will be webcast at: Program (NTP) Interagency Center for research, and (3) highlight examples of http://videocast.nih.gov/. Place: Neuroscience Center, Conference the Evaluation of Alternative how best to apply IVIVE in a tiered risk Room C/D, 6001 Executive Boulevard, Toxicological Methods (NICEATM) and decision-making strategy. Rockville, Maryland 20852. the U.S. Environmental Protection Preliminary Agenda and Other Contact Person: Glen H. Nuckolls, Ph.D., Agency (EPA) announce the workshop, Meeting Information: A preliminary Executive Secretary, Muscular Dystrophy ‘‘In Vitro to In Vivo Extrapolation for agenda and additional information will VerDate Sep<11>2014 19:33 Sep 17, 2015 Jkt 235001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 E:\FR\FM\18SEN1.SGM 18SEN1


Document Created: 2015-12-15 09:27:33
Document Modified: 2015-12-15 09:27:33
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesNovember 13, 2015.
FR Citation80 FR 56476 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR